Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | 54 | 0 | 5 | 0 | €174.00 | €167.19 | -3.915% |
| Rhythm Pharmaceuticals | 35 | 0 | 1 | 0 | €89.00 | €93.76 | 5.347% |
| Cytokinetics Inc. | 34 | 0 | 2 | 0 | €56.50 | €74.97 | 32.699% |
| MannKind Corp. | 24 | 0 | 6 | 0 | €4.88 | €8.60 | 76.060% |
| AnaptysBio Inc | 24 | 0 | 5 | 0 | €36.60 | €44.30 | 21.048% |
| Krystal Biotech | 23 | 0 | 1 | 0 | €201.20 | €206.76 | 2.763% |
| Biocryst Pharmaceuticals | 21 | 0 | 0 | 0 | €6.52 | €14.65 | 124.615% |
| Intellia Therapeutics Inc | 25 | 4 | 3 | 2 | €8.24 | €26.68 | 223.774% |
| Omeros Corp. | 19 | 0 | 2 | 0 | €9.37 | €31.39 | 234.988% |
| Verastem Inc. | 19 | 1 | 0 | 0 | €9.10 | €12.69 | 39.477% |
| Prothena Corp. plc | 18 | 1 | 1 | 0 | €9.55 | €26.75 | 180.115% |
| Ocular Therapeutix Inc. | 18 | 1 | 1 | 1 | €10.67 | €15.58 | 45.974% |
| Esperion Therapeutis.Inc. | 17 | 0 | 2 | 0 | €3.20 | €13.72 | 328.809% |
| Radnet Inc. | 17 | 1 | 3 | 0 | €67.50 | €70.90 | 5.036% |
| Catalyst Pharmaceutical Partners Inc | 16 | 0 | 3 | 0 | €20.20 | €29.84 | 47.708% |
| Addus Homecare Corp. | 16 | 1 | 1 | 0 | €99.50 | €121.14 | 21.751% |
| Atricure Inc. | 14 | 0 | 0 | 0 | €30.80 | €46.57 | 51.192% |
| Evolus Inc | 14 | 0 | 0 | 0 | €5.65 | €20.71 | 266.602% |
| Vanda Pharmaceuticals | 13 | 0 | 2 | 0 | €4.64 | €17.30 | 272.879% |
| Cytosorbents Corp. | 12 | 0 | 1 | 0 | €0.63 | €8.73 | 1290.048% |
| SI-BONE Inc | 11 | 0 | 1 | 0 | €16.30 | €21.10 | 29.448% |
| EyePoint Pharmaceuticals Inc. | 11 | 0 | 0 | 0 | €12.10 | €23.84 | 96.988% |
| Sangamo Therapeutics Inc. | 12 | 1 | 0 | 0 | €0.43 | €8.60 | 1923.765% |
| Corcept Therapeutics Inc. | 11 | 0 | 1 | 0 | €73.94 | €124.85 | 68.856% |
| Akebia Therapeutics Inc. | 12 | 1 | 2 | 0 | €1.35 | €6.16 | 358.016% |